Skip to main content
SpringerLink
Log in

Variable clinical presentation and outcome in pediatric patients with resistance to thyroid hormone (RTH)

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

An Erratum to this article was published on 18 September 2011

Abstract

Resistance to thyroid hormone (RTH) is characterized by elevated levels of thyroid hormones, normal or slightly increased TSH levels respondent to TRH, resistance to thyroid hormone administration, and variable clinical expression. To describe the diverse clinical and biochemical findings of six children from five unrelated families with molecular diagnosis of RTH (0.5–12.7 years) and their follow-up (3–20 years). All RTH patients and 4 affected parents’ harbored mutations in exons 9 or 10 of the thyroid receptor β gene: p.M313T (de novo), pN331D, p.L341P, p.L346F, and p.P453L. At consultation 5/6 had goiter, 4/6 tachycardia, and 3/5 learning disabilities. Median hormone levels were: T4 257.4 nmol/l (NR: 77.2–180.2); FreeT4 39.9 pmol/(NR:10.3–28.3); T3 4.28 nmol/l (NR:1.23–3.39) TSH 2.8 mUI/l (NR: 0.5–5) always responsive to TRH. TSH levels remained detectable after supraphysiologic T3 administration while SHBG levels showed a paradoxical decrease in 4/6. Thyroid antibodies, initially present in two subjects, became positive in other two during follow-up. All patients grew normally and presented variable symptoms that were treated according to need. Two patients developed psychiatric disorders. Only one of the four affected parents exhibited clinical signs of RTH (tachycardia and depression). Parent’s thyroid profile showed similar TSH and T3 levels but lower T4 and FT4 than their children. RTH has a distinctive biochemical profile with highly variable clinical manifestations and outcomes. Its recognition and molecular characterization avoid misleading diagnosis. Treatment has to be instituted according to each subject’s own clinical requirements.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. S. Refetoff, R. Weiss, S. Usala, The syndromes of resistance to thyroid hormone. Endocr. Rev. 14, 348–399 (1993)

    PubMed  CAS  Google Scholar 

  2. S. Refetoff, A.M. Dumitrescu, Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodination. Best Pract. Res. Clin. Endocrinol. Metab. 21(2), 277–305 (2007)

    Article  PubMed  CAS  Google Scholar 

  3. K.K. Chaterjee, Resistance to thyroid hormone. Horm. Res. 48(4), 43–46 (1997)

    Article  Google Scholar 

  4. P. Beck-Peccoz, V.K.K. Chatterjee, The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4, 225–232 (1994)

    Article  PubMed  CAS  Google Scholar 

  5. R.E. Weiss, S. Refetoff, Resistance to thyroid hormone. Rev. Endocr. Metab. Disord. 1, 97–1086 (2000)

    Article  PubMed  CAS  Google Scholar 

  6. S.H. LaFranchi, D.B. Snyder, D.E. Sesser, M.R. Skeels, N. Singh, G.A. Brent, J.C. Nelson, Follow-up of newborns with elevated screening T4 concentrations. J. Pediatr. 143, 296–301 (2003)

    Article  PubMed  Google Scholar 

  7. A. Sakurai, A. Nakai, L.J. De Groot, Structural analyses of human thyroid receptor βgene. Mol. Cell. Endocrinol. 71, 83–91 (1990)

    Article  PubMed  CAS  Google Scholar 

  8. M. Alonso, C. Goodwin, X. Liao, T. Ortiga-Carvalho, D.S. Machado, F.E. Wondisford, S. Refetoff, R.E. Weiss, In vivo interaction of steroid receptor coactivator (SRC)-1 and the activation function-2 domain of the thyroid hormone receptor (TR) beta in TRbeta E457A knock-in and SRC-1 knockout mice. Endocrinology 150(8), 3927–3934 (2009)

    Article  PubMed  CAS  Google Scholar 

  9. R.E. Weiss, Y. Hayashi, T. Nagaya, K.J. Petty, Y. Murata, H. Tunca, H. Seo, S. Refetoff, Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor. J. Clin. Endocrinol. Metab. 81, 4196–4203 (1996)

    Article  PubMed  CAS  Google Scholar 

  10. J. Pohlenz, R.E. Weiss, P. Macchia, S. Pannain, I.T. Lau, H. Ho, S. Refetoff, Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor β gene. J. Clin. Endocrinol. Metab. 84, 3919–3928 (1999)

    Article  PubMed  CAS  Google Scholar 

  11. B. Hamon, P. Hamon, M. Bovier-Lapierre, M. Pugeat, F. Savagner, P. Rodien, J. Orgiazzi, A child with resistance to thyroid hormone without thyroid hormone gene mutation: a 20 year follow up. Thyroid 18, 1 35–1 44 (2008)

    Article  Google Scholar 

  12. S. Refetoff, Resistance to thyroid hormone: one of several defects causing reduced sensitivity to thyroid hormone. Nat. Clin. Pract. Endocrinol. Metab. 4(1), 1 (2008)

    Article  PubMed  Google Scholar 

  13. A. Sakurai, T. Miyamoto, S. Refetoff, L. De Groot, Dominant negative transcriptional regulation by a mutant thyroid receptor β in a family with generalized thyroid hormone resistance. Mol. Endocrinol. 4, 1988–1994 (1990)

    Article  PubMed  CAS  Google Scholar 

  14. D. Sarne, S. Sobieszczyk, K. Ain, S. Refetoff, Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin releasing hormone stimulation and short term triiodotironine suppression. J. Clin. Endocrinol. Metab. 70, 1305–1311 (1990)

    Article  PubMed  CAS  Google Scholar 

  15. M. di Fulvio, A. Chiesa, Baranzini, L. Gruñeiro-Papendieck, A. Masini Repiso, H. Targovnik, A new point mutation (M313T) in the thyroid hormone receptor beta gene in a patient with resistance to thyroid hormone. Thyroid 7(1), 43–45 (1997)

    Article  PubMed  Google Scholar 

  16. C.M. Rivolta, M.C. Olcese, F. Belforte, A. Chiesa, L. Gruñeiro-ppaendieck, S. Iorcansky, V. Herzovich, F. Cassorla, G. Gauna, G. Gonzalez Sarmiento, H. Targovnik, Genotyping of resistance to thyroid hormone in South American population. Identification of seven novel missense mutations in the human thyroid hormone receptor b gene. Mol. Cell. Probes 23(3–4), 148–153 (2009)

    Article  PubMed  CAS  Google Scholar 

  17. D.R. Bajorunas, W. Rosner, I.A. Kourides, Use of bromocriptine in a patient with generalized resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 58(4), 731–735 (1984)

    Article  PubMed  CAS  Google Scholar 

  18. T.J. Kim, S. Travers, Case report: thyroid hormone resistance and its therapeutic challenges. Curr. Opin. Pediatr. 20(4), 490–493 (2008)

    Article  PubMed  Google Scholar 

  19. R.E. Weiss, They have ears but do not hear (Psalms 135:17): non-thyroid hormone receptor beta (non-TRbeta) resistance to thyroid hormone. Thyroid 18(1), 3–5 (2008)

    Article  PubMed  Google Scholar 

  20. O. Ercan, Thyroid hormone resistance in children. Pediatr. Endocrinol. Rev. 1(2), 191–197 (2003)

    PubMed  Google Scholar 

  21. F. Brucker Davis, M.C. Skarutis, M.B. Grace, J. Benichou, P. Hauser, E. Wiggs, B.D. Weintraub, Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. Ann. Inter. Med. 123, 572–583 (1995)

    CAS  Google Scholar 

  22. L. Persani, C. Asteria, M. Tonacchera, P. Vitti, V.K.K. Chatterjee, P. Beck-Peccoz, Evidence for the secretion of thyrotropin with enhanced bioactivity in syndromes of thyroid hormone resistance. J. Clin. Endocrinol. Metab. 78, 1034–1039 (1994)

    Article  PubMed  CAS  Google Scholar 

  23. P. Hauser, A.J. Zametkin, P. Martinez, B. Vitiello, J.A. Matochik, A.J. Mixson, B.D. Weintraub, Attention deficit hyperactivity disorder in people with generalized resistance to thyroid hormone. N. Engl. J. Med. 328, 997–1001 (1993)

    Article  PubMed  CAS  Google Scholar 

  24. S. Refetoff, H. Tunca, D.L. Wilansky, V.C. Mussey, R.E. Weiss et al., Mutation in the thyroid hormone receptor (TR) β gene (M313T) not previously reported in two unrelated families with resistance to thyroid hormone (RTH). Thyroid 6(6), 571–573 (1996)

    Article  PubMed  CAS  Google Scholar 

  25. C. Gavin, H. Meggison, T.C. Ooi, Proposing a causal link between thyroid hormone resistance and primary autoimmune hypothyroidism. Med. Hypotheses 70(5), 1024–1028 (2008)

    Article  PubMed  CAS  Google Scholar 

  26. M.S. Barkoff, M. Kocherginsky, J. Anselmo, R.E. Weiss, S. Refetoff, Autoimmunity in patients with resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 95(7), 3189–3193 (2010)

    Article  PubMed  CAS  Google Scholar 

  27. M. Kabelitz, K.P. Liesenkotter, B. Stach, H. Willgerodt, W. Stablein, W. Singendonk, E. Jager-Roman, H. Litzenborger, B. Ehnert, A. Gruters, The prevalence of anti-thyroid peroxidase antibodies and autoimmune thyroiditis in children and adolescents in an iodine replete area. Eur. J. Endocrinol. 148(3), 301–307 (2003)

    Article  PubMed  CAS  Google Scholar 

  28. J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)”. J. Clin. Endocrinol. Metab. 87(2), 489–499 (2002)

    Article  PubMed  CAS  Google Scholar 

  29. H.A. Tran, Difficulties in diagnosing and managing coexisting primary hypothyroidism and resistance to thyroid hormone. Endocr. Pract. 12, 288–293 (2006)

    PubMed  Google Scholar 

  30. T. Takeda, S. Suzuki, R.T. Liu, L. DeGroot, Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone. J. Clin. Endocrinol. Metab. 80 7, 2033–2040 (1995)

    Article  Google Scholar 

  31. P. Beck-Peccoz, G. Piscitelli, M.G. Cattaneo, G. Faglia, Treatment of hyperthyroidism due to non neoplastic pituitary TSH hypersecretion with 3, 5, 3′triiodothyrocatic acid (TRIAC). J. Endocrinol. Invest. 6, 217–223 (1983)

    PubMed  CAS  Google Scholar 

  32. G. Radetti, I. Persani, D. Molinaro, D. Mannavola, D. Cortelazzi, V.K.K. Chatterjee, P. Beck Peccoz, Clinical and hormonal outcome after two years of triiodothyroacetic acid treatment in a child with thyroid hormone resistance. Thyroid 7(5), 775–778 (1997)

    Article  PubMed  CAS  Google Scholar 

  33. G. Chiellini, J.W. Apriletti, H.A. Yoshihara, J.D. Baxter, R.C.J. Ribeiro, T.S. Scanlan, A high-affinity subtype selective agonist ligand for thyroid hormone receptor. Chem. Biol. 5, 299–306 (1998)

    Article  PubMed  CAS  Google Scholar 

  34. H.F. Ye, K.E. O’Reilly, J.T. Koh, A subtype-selective thyromimetic designed to bind a mutant thyroid hormone receptor implicated in resistance to thyroid hormone. J. Am. Chem. Soc. 123, 1521–1522 (2001)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

A. Chiesa is a research associate member of the Gobierno de la Ciudad de Buenos Aires. C. M. Olcese is a research fellow of the Universidad de Buenos Aires. H. M. Targovnik and C. M. Rivolta are established investigators of the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). This study was supported by grants from Universidad de Buenos Aires (B 078/2008 to HMT, 20020100100594/2011 to CMR), CONICET (PIP 2009/112-2000801-0054 to HMT) and ANPCyT-FONCyT (PICT 2010/05-1130 to CMR).

Author information

Authors and Affiliations

  1. División Endocrinología, Hospital de Niños “Ricardo Gutiérrez”, Centro de Investigaciones Endocrinológicas, CEDIE-CONICET, Gallo 1330, 1425, Buenos Aires, Argentina

    Ana Chiesa, Patricia Papendieck, Alicia Martinez, Ana Vieites & Laura Gruñeiro-Papendieck

  2. Laboratorio de Biología Molecular, Cátedra de Genética y Biología Molecular, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, 1113, Buenos Aires, Argentina

    Maria Cecilia Olcese, Héctor Manuel Targovnik & Carina Maria Rivolta

  3. Unidad de Pediatría Hospital Juan A Fernández Buenos Aires, Buenos Aires, Argentina

    Sonia Bengolea

Authors
  1. Ana Chiesa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Cecilia Olcese
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Patricia Papendieck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alicia Martinez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ana Vieites
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sonia Bengolea
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Héctor Manuel Targovnik
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Carina Maria Rivolta
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Laura Gruñeiro-Papendieck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ana Chiesa.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s12020-011-9533-7.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chiesa, A., Olcese, M.C., Papendieck, P. et al. Variable clinical presentation and outcome in pediatric patients with resistance to thyroid hormone (RTH). Endocrine 41, 130–137 (2012). https://doi.org/10.1007/s12020-011-9518-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-011-9518-6

Keywords

Search

Navigation